Mobile in Clinical Trials

#MobileClin2024 will provide frontline feedback, real-world results, and opportunities to engage with a 360 community! There is less than a month before our annual conference supporting more patients to participate remotely in clinical research. 🔗 Learn more about Mobile in Clinical Trials 2024: https://lnkd.in/ggv8w76s #mobiletechnology #conference #clinicalresearch #innovation

Adama Ibrahim, EMBA of Novo Nordisk has been attending Mobile in Clinical Trials for five years! She has noticed the industry’s shift towards a more “human-centric approach of bringing in the user’s perspective, and understanding their journey”, which is a key theme at #MobileClin2024. Learn more about Mobile in Clinical Trials 2024, the leading conference for patient technologies in research: https://lnkd.in/ggv8w76s #conference #clinicaltrials #mobiletechnology

Hear why Kai Bode of Merck comes to Mobile in Clinical Trials! He believes speakers “leave after they present with actual feedback and an understanding of what they can do differently”, making ‘intellectual generosity’ a core theme throughout the conference. 🔗 Find more information on Mobile in Clinical Trials 2024 here: https://lnkd.in/ggv8w76s #MobileClin2024 #mobiletechnology #conference #clinicalresearch

Join us at #MobileClin2024 for our Annual Technology Showcase! Representatives from Verisense Health, Spencer Health Solutions, Inc., IQVIA, and Delve Health will present their unique technologies, followed by 15 minutes of live demonstrations and Q&A. 🔗 Find more information on Mobile in Clinical Trials 2024 here: https://lnkd.in/ggv8w76s #technology #mobiletechnology #clinicaltrials

While decentralized clinical trials steadily rise in popularity, new technologies are being developed to accommodate for this interest. Dr Dina Katabi of Massachusetts Institute of Technology explains how invisible remote monitoring may be the next breakthrough for clinical research. Read the article below! 📝 https://lnkd.in/eJbjcMSC 🔗 Learn more about Mobile in Clinical Trials 2024, the leading conference for patient technologies in research: https://lnkd.in/ggv8w76s #mobiletechnology #innovation #AI #clinicalresearch

Rinol Alaj, Senior Director, Head of Clinical Operations at Regeneron and speaker at #DPHARM2024, discusses how they approach using digital biomarkers in trials, addressing the critical questions behind their implementation. "You need to be smart about what you’re investing your resources in, but it always comes back to the unmet need and the value you’re bringing." Read the article here: https://lnkd.in/e4xPW45v #clinicalresearch #clinicaltrials #digitalbiomarker

When promoting patient accessibility, researchers must consider the potential of added patient burden. Hear from pharma leaders at Pfizer, Regeneron, Merck, and others on how they are using mobile technology to curtail this issue in the podcast below! 🎙️ https://lnkd.in/gizH-EQd 🔗 Find more information about Mobile in Clinical Trials 2024, the leading conference for patient technologies in research: https://lnkd.in/ggv8w76s #MobileClin2024 #mobiletechnology #clinicalresearch

“One single company cannot solve a problem. Whether it being at a digital endpoint or new modalities, we have to work together across the industry.” Listen to industry leaders Adama Ibrahim, EMBA, Dr Susie Stephens and Thomas Lonborg-Jensen at Novo Nordisk, Angela Radcliffe at Bristol Myers Squibb, Kailash Swarn at Accenture, and Dr Ingrid Sofie Harbo at Lundbeck discuss end-to-end digital transformation! Watch the full video linked below. 📽️ https://lnkd.in/gJBRHuqM 🔗 Learn more about Mobile in Clinical Trials 2024, the leading conference for patient technologies in research: https://lnkd.in/ggv8w76s #digitalhealthtech #digitalinnovation #mobiletechnology #clinicalresearch

Representatives from Regeneron, Takeda, Medidata Solutions, and Mitsubishi Tanabe Pharma America will be speaking on the adoption of novel endpoints and digital biomarkers through wearable devices. We’re excited to hear about these technological advancements and their role in modernizing trial methodologies! Learn more about #MobileClin2024 here: https://lnkd.in/ggv8w76s #mobiletechnologies #clinicalresearch #clinicaltrials

Connect with Tufts CSDD Data Scientist and Project Manager Zachary Smith on September 16 at Mobile in Clinical Trials in Philadelphia, PA held by The Conference Forum. Zak will moderate a discussion on “Demonstrating the Value and ROI of Digital Technologies in Trials” with panelists Jakob Alme of Sage Therapeutics, Greg Christie of StudyKIK, a Syneos Health Company, Christina Fawcett of GSK, Alex S. of Bristol Myers Squibb, and Edward Triebell of Medical Research Network. To learn more and connect, visit https://lnkd.in/esx_v_yA